Business
KKR-led Consortium Drives Further Investment in Sylvan
BEIJING, January 21, 2026--KKR-led Consortium Drives Further Investment in Sylvan
About this update from Kkr & Co. Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/47c3ed92686f54851b5478479d919608"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KGkwy8ZUxboCsfhYXxFQjw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/47c3ed92686f54851b5478479d919608","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/UrfZ7X5PQPng2Qpav4HM2Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/47c3ed92686f54851b5478479d919608","width":1024,"height":512}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/775869f1b7c210749198ab2dbcf18c49"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ASAxwUfYpWJ9qm_KukLKhQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/775869f1b7c210749198ab2dbcf18c49","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/U7NEsu6akuYom0ypm.RtKQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/775869f1b7c210749198ab2dbcf18c49","width":1024,"height":512}}},{"type":"text","content":"BEIJING, January 21, 2026--(BUSINESS WIRE)--Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology company (the "Company"), through funds managed by KKR with participation from new investors and a follow-on investment from existing investor, Novo Holdings, which increased its ownership stake in the Company as part of this round. Following the investment, KKR remains the majority investor in Sylvan.","length":490,"tagName":"p"},{"type":"text","content":"Founded in 1932, Sylvan is a world-leading mushroom spawn and fungal biotechnology company. The company seeks to harness the potential of fungal systems to create sustainable solutions to address global challenges in food, health, agriculture, and materials. Today, the Company operates multiple production facilities around the world and serves cus...